Abstract
(Benzimidazol-2-yl)-7-hydroxycoumarin and N-(2-hydroxyphenyl)-7-hydroxycoumarin-3-carboxamide have been synthesized by the condensation of ethyl 7-hydroxycoumarin-3-carboxylate in acetic acid. Acetylation with acetic anhydride and halogenation with bromine in acetic acid’s presence of the previous compounds has yielded the corresponding acetoxy and dibromo derivatives. The synthesized molecules that contain coumarin ring have been evaluated for their activities against breast cancer and they have shown good in vitro antiproliferative activities against a human breast cancer line (MCF-7). The results have shown that 3-(benzimidazol-2-yl)-7-acetoxycoumarin had a significant cytotoxic effect compared to the standard DOX (doxorubicin) drug.
Similar content being viewed by others
REFERENCES
Labanauskas, L., Brukstus, A., Udrenaite, E., Gaidelis, P., and Bucinskaite, V., Chemija, 2003, vol. 14, pp. 49–51.
Labanauskas, L.K., Brukstus, A.B., Gaidelis, D.G., Bucinskaite, V., Udrenaite, E.B., and Duksas, V. K., Pharm. Chem. J., 2000, vol. 34, pp. 353–355.
Kataev, V.A., Khaliullin, A.N., Nasyrov, Kh.M., and Gailyunas, I.A., RF Patent RU2215002, Chem. Abstr., 2004, vol. 141, p. 7110.
Sondhi, M.S., Singh, N., Kumar, A., Lozach, O., and Meijer, L., Bioorg. Med. Chem., 2006, vol. 14, pp. 3758–3765.
Bordon, P.F. and Haesslein, J.L., Fr. Demande FR 20040820; Chem. Abstr., 2004, vol. 141, p. 206 968.
Clerc, F., Hamy, F., Depaty, I., Angouillant, B.O., and Roesner, M., EU Patent EP20030402, Chem. Abstr., 2003, vol. 138, p. 271 683.
Cho, J.M., Ro, S., Lee, T.G., Lee, K.J., Shin, D., Hyun. Y.Z., Lee, S.C., Kim, J.H., and Jeon, Y.H., PCT Int. Appl. WO2004065370, Chem. Abstr., 2004, vol. 141, p. 174 171.
Pandey, K.V., Upadhyay, M., Upadhyay, M., Gupta, D.V., and Tandon, M., Acta Pharm., 2005, vol. 55, pp. 47–56.
Salem, M.A., Marzouk, M.I., and El-Kazak, A.M., Molecules, 2016, vol. 21, pp. 249–269.
Morsy, S.A., Farahat, A.A., Nasr, M., and Tantawy, A.S., Saudi Pharm. J., 2017, vol. 25, pp. 873–884.
Huang, Y.X., Shan, J.Z., Zhai, L.H., Su, L., and Zhang, Y.X., Chem. Biol. Drug. Res., 2011, vol. 78, pp. 651–658.
Kudo, E., Taura, M., Matsuda, K., Shimamoto, M., Kariya, R., Goto, H., Hatlori, S., Kimura, S., and Okada, S., Bioorg. Med. Chem. Lett., 2013, vol. 23, pp. 606–609.
Rocha, F.S., Codeceira, G.S., Oliveira, M.D.L., and Andrade, C.A.S., J. King Saud Univ. Sci., 2018, vol. 31, pp. 452–459.
Nitiema, W.L., Savadogo, A., Simpore, J., Dianou, D., and Traore, S.A., Int. J. Microbiol. Res., 2012, vol. 3, pp. 183–187.
Kostova, I., Bhatia, S., Grigorov, P., Balkansky, S., Parmar, S.V., Prasad, K.A., and Saso, L., Curr. Med. Chem., 2011, vol. 18, pp. 3929–3951.
Duarte, F.J., Liao, L.S., Vaeth, K.M., and Miller, A.M., J. Opt. A., 2006, vol. 8, pp. 172–174.
Agarwal, R., Biochem. Pharmacol., 2000, vol. 60, pp. 1051–1059.
Sabt, A., Abdelhafez, O.M., El-Haggar, R.S., Madkour, H.M.F., Eldehna, W.M., El-Khrisy, E.E.-D. A.M., Abdel-Rahman, M.A., and Rashed, L.A., J. Enzym. Inhib. Med. Ch., 2018, vol. 33, pp. 1095–1107.
Benci, k., Mandic, L., Suhina, T., Sedic, M., Klobucar, M., Pavelic, K.S., Wittine, K., and Mintas, M., Molecules, 2012, vol. 17, pp. 11 010–11 025.
Marshall, E.M., Kervin, K., Benefield, C., Umerani, A., Albainy-Jenei, S., Zhao, Q., and Khazaeli, B.M., J. Cancer Res. Clin. Oncol., 1994, vol. 120, pp. 3–10.
Rehman, S., Rahman, M., Tripathi, K.V., Singh, J., Ara, T., Koul, S., Farooq, S., and Kaul, A., Bioorg. Med. Chem. Lett., 2014, vol. 24, pp. 4243–4246.
Zhang, W., Li, Z., Zhou, M., Wu, F., Hou, X., Luo, H., Han, X., Yan, G., Ding, Z., and Li, R., Bioorg. Med. Chem. Lett., 2014, vol. 24, pp. 799–807.
Wang, J., Lu, L.M., Dai, L.H., Zhang, P.S., Wange, X.H., and Wei, N., Bar. J. Med. Biol. Res., 2015, vol. 48, pp. 245–253.
Musa, A.M., Joseph, Y.M., Latinwo, M.L., Badisa, V., and Cooperwood, S.J., Anticancer Res., 2015, vol. 35, pp. 653–660.
Khaghanzadeh, N., Mojtagedi, Z., Ramezani, M., Erfani, N., and Ghaderi, A., DARU J. Pharm. Sci., 2012, vol. 20, pp. 20–69.
Singh, R.K., Lange, T.S., and Kim, K.K., Inverst. New Drugs, 2011, vol. 29, pp. 63–72.
EL-Deen, I.M., J. Serb. Chem. Soc., 1998, vol. 63, pp. 367–370.
EL-Deen, I.M., Chines J. Chem., 1998, vol. 16, pp. 533–537.
EL-Deen, I.M., Chines J. Chem., 1998, vol. 16, pp. 528–532.
EL-Deen, I.M., Chines J. Chem., 1999, vol. 17, pp. 391–397.
EL-Deen, I.M. and Abd El-Fatah, M.E., J. Serb. Chem. Soc., 2000, vol. 65, pp. 95–102.
El-Deen, I.M. and Ibrahim, H.K., Chem. Papers, 2004, vol. 58, pp. 200–204.
El-Deen, I.M., Mahdy, A.R.E., and Al-Saleem, M.S., Mens Agitat., 2018, vol. 13, pp. 18–21.
El-Deen, I.M., Elgareib, M.S.A., Mahdy, A.R.E., and Al-Saleem, M.S., Mens Agitat., 2018, vol. 13, pp. 1–5.
ACKNOWLEDGMENTS
The authors are thankful to nuclear magnetic resonance lab in faculty of pharmacy, Mansoura University and nuclear magnetic resonance lab in Beni-suef University for using their laboratory equipments during.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
This article does not contain any studies involving human participants or animals performed by any of the authors in this work.
Conflict of Interests
Authors declare there are no conflicts of interests.
Additional information
Corresponding author: phone: +2 (0106) 212-40-68.
Rights and permissions
About this article
Cite this article
Eman M. Radwan, Elsayed, E.H., El-Moneim, M.A. et al. Design, Synthesis, and Anti-Breast Cancer Activity of Some Hybrid Molecules Containing Coumarin Moiety. Russ J Bioorg Chem 47, 149–157 (2021). https://doi.org/10.1134/S1068162021010180
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162021010180